Structural analysis of human alpha-class glutathione transferase A1-1 in the apo-form and in complexes with ethacrynic acid and its glutathione conjugate

Structure
A D CameronT A Jones

Abstract

Glutathione transferases (GSTs) constitute a family of isoenzymes that catalyze the conjugation of the tripeptide glutathione with a wide variety of hydrophobic compounds bearing an electrophilic functional group. Recently, a number of X-ray structures have been reported which have defined both the glutathione- and the substrate-binding sites in these enzymes. The structure of the glutathione-free enzyme from a mammalian source has not, however, been reported previously. We have solved structures of a human alpha-class GST, isoenzyme A1-1, both in the unliganded form and in complexes with the inhibitor ethacrynic acid and its glutathione conjugate. These structures have been refined to resolutions of 2.5 A, 2.7 A and 2.0 A respectively. Both forms of the inhibitor are clearly present in the associated electron density. The major differences among the three structures reported here involve the C-terminal alpha-helix, which is a characteristic of the alpha-class enzyme. This helix forms a lid over the active site when the hydrophobic substrate binding site (H-site) is occupied but it is otherwise disordered. Ethacrynic acid appears to bind in a non-productive mode in the absence of the coenzyme glutathione.

References

Feb 1, 1992·Protein Expression and Purification·G StenbergB Mannervik
Jan 1, 1992·Critical Reviews in Biochemistry and Molecular Biology·S Tsuchida, K Sato
Apr 1, 1992·Proteins·A L MorrisJ M Thornton
Mar 1, 1991·Chemical Research in Toxicology·R N Armstrong
Mar 1, 1991·The Biochemical Journal·D J MeyerB Ketterer
Mar 1, 1991·Acta Crystallographica. Section A, Foundations of Crystallography·T A JonesM Kjeldgaard
Jul 17, 1990·Biochemistry·E LolisG A Petsko
Jul 1, 1990·Acta Crystallographica. Section A, Foundations of Crystallography·A T BrüngerJ W Erickson
Aug 1, 1990·The Biochemical Journal·B van OmmenP J van Bladeren
Jan 1, 1989·Annual Review of Biochemistry·C B Pickett, A Y Lu
Jul 20, 1989·Journal of Molecular Biology·S W CowanB Mannervik
Jan 1, 1988·CRC Critical Reviews in Biochemistry·B Mannervik, U H Danielson
Nov 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·B MannervikH Jörnvall
Mar 16, 1994·Biochimica Et Biophysica Acta·M C Wilce, M W Parker
Aug 1, 1993·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·J H PloemenP J van Bladeren
Sep 1, 1994·Acta Crystallographica. Section D, Biological Crystallography·UNKNOWN Collaborative Computational Project, Number 4

❮ Previous
Next ❯

Citations

Jan 1, 1997·Proteins·G ChelvanayagamP G Board
Aug 9, 2007·Marine Biotechnology·Brian BlanchetteBal Ram Singh
Aug 15, 2013·Journal of Inorganic Biochemistry·Yu LinShaoxiang Xiong
Jul 20, 2000·Proceedings of the National Academy of Sciences of the United States of America·L O NilssonB Mannervik
Apr 22, 2008·The Journal of Biological Chemistry·Larissa M BaloghWilliam M Atkins
Oct 18, 2001·Protein Science : a Publication of the Protein Society·A J OakleyM C Wilce
Nov 19, 2003·Proceedings of the National Academy of Sciences of the United States of America·Karin Fritz-WolfKatja Becker
Apr 17, 2013·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·Ghalib K BardaiGeoffrey I Sunahara
Jan 7, 1999·FEBS Letters·M L van IerselP J van Bladeren
Nov 6, 2012·Trends in Pharmacological Sciences·Baojian Wu, Dong Dong
Sep 25, 2004·Protein Science : a Publication of the Protein Society·Jim Warwicker
Aug 19, 2005·Biopolymers·Sofia Hederos, Lars Baltzer
Sep 16, 2008·Chemistry : a European Journal·Daniel F A R DouradoMaria João Ramos
Sep 26, 2009·Protein Science : a Publication of the Protein Society·Indalecio Quesada-SorianoLuis García-Fuentes
May 6, 2006·Bioorganic & Medicinal Chemistry Letters·Dean Y MaedaJohn A Zebala
Mar 24, 2011·Drug Metabolism Reviews·Jack U Flanagan, Mark L Smythe
Mar 25, 2011·Drug Metabolism Reviews·Aaron Oakley
Mar 16, 2011·Drug Metabolism Reviews·Larissa M Balogh, William M Atkins
Jun 19, 2013·Chemico-biological Interactions·Yaman MusdalBengt Mannervik

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.